About Index Trending news
Analyze
Pricing
Theravance

Theravance

Theravance

Theravance develops small molecule medicines for respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Elsewhere

Alexa global traffic share

29 Nov 2010
$129,375,000
Private equity